Cross-linked Hyaluronic Acid/dextranomer for the Treatment of Stress Urinary Incontinence

ConditionUrinary Stress Incontinence (SI)

Trial statusNot yet recruiting

Trial phasePhase 2

Trial typeInterventional

Biological sexFemale

Age18-75

SponsorIzmir Bakircay University

About this trial

The investigators aimed to evaluate the effectiveness and safety of intraurethral cross-linked hyaluronic acid/dextranomer (CLHA/Dx) injection for the treatment of stress urinary incontinence (SUI) in women.

Eligibility criteria

Qualifiers

Diagnosis of Stress Urinary Incontinence.

Presence of incontinence during the Valsalva maneuver.

Positive Marshall-Marchetti test result.

Post-void residual urine volume of ≤100 mL.

Disqualifiers

Temporary urinary incontinence.

Delirium.

Urinary tract infection.

Urethritis.

Trial design

Treatments tested in this trial

Intraurethral injection
Mid-urethral sling

Treatment groups

60 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Izmir Bakircay University

Lead sponsor

Source ClinicalTrials.gov